Skip to content

CT and MRI in diagnosis, differential diagnosis and preoperative staging of renal tumors

CT and MRI in diagnosis, differential diagnosis and preoperative staging of renal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-11001536
Enrollment
Unknown
Registered
2011-07-17
Start date
2011-07-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal tumor

Interventions

Gold Standard:
Index test:

Sponsors

Department of Urology, Peking university first hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patient who is doubt with renal tumor; 2. no age and gender restricted; 3. patient who signs the informed consents voluntarily; 4. patient without contraindications of CT and/ or MRI examination;

Exclusion criteria

Exclusion criteria: exclusion of CT examination 1. patient who is allergic to any component of Iodine contrast agents; 2. patient with hyperthyroidism or malignant thyroid tumor; 3. Patient with severe damage of renal function, defined as GFR<30mL/min1.73m2; 4. Pregnant or maybe pregnant woman; 5. Patient without good consciousness who may not complete the examination; 6. Patient with serious heart failure(NYHA 3-4); Patient with pacemaker, heart valve or other implants which cannot approach strong magnetic field; 7. patient with other X-ray examination within 72 hours to 7days before the contrast enhanced CT examination; 8. patient with other clinical trial within 30 days before the contrast enhanced CT examination; Exclusion of MRI examination 1.patient who is allergic to any component of Gadolinium contrast agents(if patient agree to take the contrast enhanced MR examination); 2. Patient with severe damage of renal function, defined as GFR<30mL/min1.73m2; 3. Patient with pacemaker, aneurysm clip or other implants which cannot approach strong magnetic field; 4. Pregnant or maybe pregnant woman; 5. Patient without good consciousness who may not complete the examination; 6. patient with Claustrophobia.

Design outcomes

Primary

MeasureTime frame
stage of malignant tumor;CT findings of tumor;fMRI findings fo tumor;Pathological benign or malignant;MR findings of tumor;subtype of malignant tumor;grade of malignant tumor;

Countries

China

Contacts

Public ContactXiaoying Wang
cjr.wangxiaoying@vip.163.com+86 10 83572097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026